Acute Toxicity Results from the Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity (RADIO) Trial Comparing Chemoradiation (CRT) with Cisplatin Q3weekly to Weekly for Locally Advanced Squamous Cell Carcinoma of the Head and neck (LASCCHN)

E Winquist,R Kim,K Chan,G Pond,P Francis,L Bordeleau,M Black,S Mortuza,D.A Palma,J Andrews,L Bailey,B.M Meyers,S Ghedira,S.J Hotte,P Stewart,A Nichols,C Parker,S Kuruvilla,M Smoragiewicz,C Hickling

doi:10.1016/j.ijrobp.2024.01.027

Acute Toxicity Results from the Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity (RADIO) Trial Comparing Chemoradiation (CRT) with Cisplatin Q3weekly to Weekly for Locally Advanced Squamous Cell Carcinoma of the Head and neck (LASCCHN)

E Winquist, R Kim + Show 18 more

https://doi.org/10.1016/j.ijrobp.2024.01.027

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics

Publication Date: Mar 14, 2024

#Locally Advanced Squamous Cell Carcinoma Of The Head And Neck #Advanced Squamous Cell Carcinoma + Show 2 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Acute Toxicity Results from the Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity (RADIO) Trial Comparing Chemoradiation (CRT) with Cisplatin Q3weekly to Weekly for Locally Advanced Squamous Cell Carcinoma of the Head and neck (LASCCHN)

Full Text